MAPT and Alzheimer disease: Besides activation of the cPLA2/PGE2 pathway, CaSR has also been reported to be involved in the Aβ-induced increase of Aβ and phospho-tau (Dal Prà et al., 2014; Chiarini et al., 2017); this might also contribute to the decrease in cognitive decline in AD mice.